Concepedia

Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin’s disease

DE Reece, TJ Nevill, Antoine Sayegh, JJ Spinelli, DA Brockington, MJ Barnett, H-G Klingemann, JM Connors, S.H. Nantel, JD Shepherd,

Bone Marrow Transplantation · 1999 · 33 citations · 0 references

Concepts

MedicineOncologyPharmacologyCancer Drug Toxicity ManagementChemotherapyStem Cell TransplantationCell Therapy ToxicityChemotherapy Toxicity ManagementCytotoxic ChemotherapyHigh-dose ChemotherapyTransplant-related ToxicitiesAutologous Stem Cell TherapyConditioning Regimen ToxicityHodgkin Lymphoma TherapyHodgkin Lymphoma TreatmentNon-hodgkin Lymphoma TherapyNon-hodgkin Lymphoma TreatmentNon-relapse MortalityRegimen-related Toxicity